Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7785-7793
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7785
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7785
Table 1 Baseline characteristics of patients with papillary adenoma
No. | Sex | Age in yr | Tumor size in mm | Biopsy pathology |
1 | M | 59 | 20 | Tubular adenoma |
2 | M | 60 | 15 | Tubular adenoma and HGD |
3 | M | 49 | 32 | Adenomatoid hyperplasia and LGD |
4 | M | 44 | 20 | Tubular adenoma |
5 | M | 50 | 10 | Neuroendocrine tumor (stage G1) |
6 | F | 86 | 40 | HGD |
7 | M | 56 | 43 | Tubular adenoma and HGD |
8 | F | 52 | 20 | Tubular adenoma |
- Citation: Liu SZ, Chai NL, Li HK, Feng XX, Zhai YQ, Wang NJ, Gao Y, Gao F, Wang SS, Linghu EQ. Prospective single-center feasible study of innovative autorelease bile duct supporter to delay adverse events after endoscopic papillectomy. World J Clin Cases 2022; 10(22): 7785-7793
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7785.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7785